Methodology for AACT evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning

Clinical Toxicology

Volumn 53, Issue 6, 2015, Pages 557-564

  Gosselin, Sophie ^a   Morris, Martin ^b   Miller Nesbitt, Andrea ^b   Hoffman, Robert S ^c   Hayes, Bryan D ^d   Turgeon, Alexis F ^e   Gilfix, Brian M ^a   Grunbaum, Ami M ^a   Bania, Theodore C ^f   Thomas, Simon H L ^g   Morais, José A ^h   Graudins, Andis ⁱ   Bailey, Benoit ^j   Mégarbane, Bruno ^k   Calello, Diane P ^l   Levine, Michael ^m   Stellpflug, Samuel J ⁿ   Hoegberg, Lotte C G ^o   Chuang, Ryan ^p   Stork, Christine ^q   Bhalla, Ashish ^r   Rollins, Carol J ^s   Lavergne, Valéry ^t   more..

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^e Université Laval   (Canada)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h MCGILL UNIVERSITY   (Canada)

ⁱ MONASH UNIVERSITY   (Australia)

^j UNIVERSITY OF MONTREAL   (Canada)

^k HÔPITAL LARIBOISIÈRE   (France)

^l Morristown Medical Center   (United States)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ REGIONS HOSPITAL   (United States)

^o Mental Health Services CPH   (Denmark)

^p UNIVERSITY OF CALGARY   (Canada)

^q SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^r POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^s UNIVERSITY OF ARIZONA   (United States)

^t HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

more..

Author keywords

Adverse effect; ; Efficacy; Fat emulsion; Intravenous lipid emulsion; Lipid interference; Lipid resuscitation; Recommendation

Indexed keywords

LIPID EMULSION; ANTIDOTE; LOCAL ANESTHETIC AGENT;

ARTICLE; CHRONIC KIDNEY DISEASE; DECISION MAKING; DELPHI STUDY; DRUG TOXICITY; EVIDENCE BASED PRACTICE; HEART ARRHYTHMIA; HUMAN; INTOXICATION; LOCAL ANESTHETIC SYSTEMIC TOXICITY; PRACTICE GUIDELINE; PUBLICATION; RESUSCITATION; SEIZURE; CONSENSUS; DIAGNOSIS; DRUG THERAPY; EVIDENCE BASED MEDICINE; STANDARDS; TREATMENT OUTCOME;

ANESTHETICS, LOCAL; ANTIDOTES; CONSENSUS; DELPHI TECHNIQUE; EVIDENCE-BASED MEDICINE; FAT EMULSIONS, INTRAVENOUS; HUMANS; POISONING; TREATMENT OUTCOME;

EID: 84931468197     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2015.1052498     Document Type: Article

References (23)

1. Sites BD, Taenzer AH, Herrick MD, Gilloon C, Antonakakis J, Richins J, Beach ML. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks: an analysis from a prospective clinical registry. Reg Anesth Pain Med 2012; 37: 478-482.
2. Mowry JB, Spyker DA, Cantilena LR, Jr., Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers'National Poison Data System (NPDS): 30th annual report. Clin Toxicol 2013; 51: 949-1229.
3. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 1998; 88: 1071-1075.
4. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105: 217-218.
5. Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. A nn Emerg Med 2008; 51: 412-415, 415 e1.
6. American College of Medical Toxicology. ACMT position statement: interim guidance for the use of lipid resuscitation therapy. JMed Toxicol 2011; 7: 81-82.
7. Jamaty C, Bailey B, Larocque A, Notebaert E, Sanogo K, Chauny JM. Lipid emulsions in the treatment of acute poisoning: A systematic review of human and animal studies. Clin Toxicol 2010; 48: 1-27.
8. Cave G, Harvey M, Graudins A. Review article: Intravenous lipid emulsion as antidote: A summary of published human experience. Emerg Med Australas 2011; 23: 123-141.
9. Waring WS. Intravenous lipid therapy: A systematic review of published case reports. Clin Toxicol 2012; 50: 365-366.
10. Butterworth JF 4th. Models and mechanisms of local anesthetic cardiac toxicity: A review. Reg Anesth Pain Med 2010; 35: 167-176.
11. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is " quality of evidence" and why is it important to clinicians? BMJ 2008; 336: 995-998.
12. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182: E839-E842.
13. Institute Of Medicine. Clinical Practice Guidelines We Can Trust. Washington DC: National Academies Press, 2011.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535.
15. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
16. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. JClin Epidemiol 2008; 61: 344-349.
17. Gagnier JJ, Riley D, Altman DG, Moher D, Sox H, Kienle G, CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. Dtsch Arztebl Int 2013; 110: 603-608.
18. Lavergne V, Ouellet G, Bouchard J, Galvao T, Kielstein JT, Roberts DM, et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial 2014; 27: 407-414.
19. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
20. Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernandez AM, et al. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007; 30: 367-373.
21. Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, Liberati A, et al. Incorporating considerations of resources use into grading recommendations. BMJ 2008; 336: 1170-1173.
22. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica, CA2011. Available from: http://www.rand. org.(Last Accessed on 15 December 2014).
23. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: A proposal from the conference on guideline standardization. Ann Intern Med 2003; 139: 493-498.